The abstract names RNA interference as a cutting-edge technology relevant to pest management innovation.
First-pass extracted concept
RNA interference
Candidate: concept label5 source documents14 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
microRNA, RNAi, short hairpin RNA, small interfering RNA
Extracted Explainers
What the tool is doing
RNA interference regulates the activity of native and foreign genes. In plants, the abstract states that it is extensively used in immune responses.
RNA interference is described as a targeted gene-therapy modality using noncoding RNAs including microRNA, siRNA, and shRNA.
Resources required
What problem it solves
It is framed as a biotechnology approach for managing insect herbivores.
The review frames RNA interference as a basis for plant defence against pathogenic microorganisms.
It is presented as a way to induce normal gene or protein expression in affected retinal cells.
What it does not solve
The abstract does not claim that these engineered approaches have solved field deployment challenges, and instead notes validation and regulatory limits.
The abstract does not provide disease-specific efficacy claims and notes ongoing engineering and delivery limitations.
Evidence Snippets
Editorial: Advancing plant defense: genome editing, RNAi, and synthetic biology for sustainable pest control.
The review further discusses insect counterstrategies and explores cutting-edge technologies-CRISPR/Cas9, RNA interference, and metabolic engineering that are reshaping pest management.
The RNA interference machinery is crucial for regulating the activity of both native and foreign genes across all eukaryotes.
RNA interference with noncoding RNAs (i.e., microRNA, small interfering RNA, short hairpin RNA)
Supported conservatively by the supplied web research summary, which identifies the anchor record as a landmark Cell review on dsRNA-triggered gene silencing/RNA interference.
Supporting Sources
Linked Claims
The editorial frames advancing plant defense for sustainable pest control in terms of genome editing, RNA interference, and synthetic biology.
RNA interference is being applied for development of novel plant defence strategies.
Quoted textsource-backed
Additionally, recent biotechnological advancements are discussed, with an emphasis on the application of RNA interference for the development of novel plant defence strategies.
Plants exhibit remarkable diversity in RNA interference core protein families and extensively use RNA interference in immune responses.
Quoted textsource-backed
However, plants exhibit remarkable diversity within each family and extensively use RNA interference mechanisms in their intricate immune responses.
Core protein families involved in RNA interference are Dicer-like, Argonaute, and RNA-dependent RNA polymerase.
Quoted textsource-backed
The core protein families involved in this process are Dicer-like, Argonaute, and RNA-dependent RNA polymerase.
Plant diseases cause an estimated 220 billion dollars in annual damage, with microorganisms accounting for approximately 150 billion dollars.
Quoted textsource-backed
Plant diseases cause an estimated $220 billion in annual damage, with microorganisms accounting for approximately $150 billion.
RNA interference machinery is crucial for regulating native and foreign gene activity across eukaryotes.
Quoted textsource-backed
The RNA interference machinery is crucial for regulating the activity of both native and foreign genes across all eukaryotes.
The source states that major challenges for engineered anti-herbivore traits include limited field validation, ecological trade-offs, and regulatory hurdles.
The source states that CRISPR/Cas9, RNA interference, and metabolic engineering are cutting-edge technologies reshaping pest management.
Vector choice and engineering methods are important considerations in optogenetics and targeted gene therapies for inherited retinal diseases.
Quoted textsource-backed
The importance of vector choice and engineering methods are discussed.
Engineering and cell or tissue delivery capabilities are limiting challenges for prompt clinical introduction of optogenetics and targeted gene therapy.
Quoted textsource-backed
the challenges limiting their prompt introduction into the clinical practice (i.e., engineering, cell or tissue delivery capabilities)
Targeted gene therapies based on CRISPR-Cas9 and RNA interference are described as inducing normal gene or protein expression into affected cells.
Quoted textsource-backed
targeted gene therapies, such as methods based on CRISPR-Cas9 and RNA interference with noncoding RNAs (i.e., microRNA, small interfering RNA, short hairpin RNA), consists of inducing normal gene or protein expression into affected cells.
Optogenetics and targeted gene therapies are presented as having clinical potential for inherited retinal diseases and personalized medicine.
Quoted textsource-backed
optogenetics and targeted gene therapies have shown great clinical potential and novelty in the branch of personalized medicine and inherited retinal diseases (IRDs).
The review appears to sit in a cross-kingdom silencing context that includes plant posttranscriptional gene silencing and fungal quelling alongside RNA interference.
The source is positioned as a review of dsRNA-triggered gene silencing that overlaps strongly with RNA interference terminology and literature.